Skip to content
Loading…
Multiple banks are competing to join a $4.25 billion debt financing backing Curium’s acquisition of radiopharmaceutical company Lantheus Holdings Inc., before the deal is syndicated to investors next year.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.